SonoThera is the world’s first ultrasound-guided gene delivery platform designed to overcome limitations of current gene therapy approaches.
Location: United States
Total raised: $185.75M
Investors 2
| Date | Name | Website |
| 22.09.2024 | Foothill V... | foothill.v... |
| 02.01.2023 | Medical Ex... | medexcelca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.01.2026 | Series B | $125M | - |
| 05.12.2022 | Series A | $60.75M | - |
Mentions in press and media 4
| Date | Title | Description |
| 10.01.2026 | SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials | SonoThera announced it will officially launch a $125 million Series B funding round at the 44th annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026, as the company looks to advance multiple genetic m... |
| 17.06.2024 | ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research | International scientific meeting convenes in Bangkok, Thailand, for the first time highlighting the important work of the Asian-Pacific scientific and clinical community BANGKOK, June 17, 2024 /PRNewswire/ -- Today, the International Societ... |
| 05.12.2022 | SonoThera Closes $60.75M Series A Funding | SonoThera, a South San Francisco, CA-based biotechnology company, raised $60.75M in Series A funding. The round was led by ARCH Venture Partners, with participation from Illumina Ventures, Johnson & Johnson Innovation, JJDC, Vertex Vent... |
| - | SonoThera | - |